Title:
PHARMACEUTICAL COMPOSITION FOR PROVIDING TREATMENT FOR OR PREVENTING ALPORT SYNDROME
Document Type and Number:
WIPO Patent Application WO/2023/085396
Kind Code:
A1
Abstract:
The present invention relates to providing a pharmaceutical composition that is useful for treating Alport syndrome. The present invention provides a pharmaceutical composition that is useful for treating Alport syndrome and contains a compound, or a pharmaceutically acceptable salt thereof, represented by general formula (I) or (II) below [wherein, A is a C6 to C10 aryl group or heteroaryl group (at least one hydrogen atom of the aryl group or the heteroaryl group may be substituted with a substituent selected from a prescribed group), R is a hydrogen atom or a C1 to C6 alkyl group, R1 is a hydrogen atom or halogen atom, and Y is a hydrogen atom, a fluorine atom, or a hydroxy group].
Inventors:
KOMORI KENICHI (JP)
YAMADA HARUKA (JP)
SHIMIZU HAYATO (JP)
AGA YASUHIRO (JP)
OGAWA AYUMI (JP)
HASEGAWA TOORU (JP)
MATSUSHITA TAKASHI (JP)
TOKUNAGA YASUNORI (JP)
ONUMA KAZUHIRO (JP)
YAMADA HARUKA (JP)
SHIMIZU HAYATO (JP)
AGA YASUHIRO (JP)
OGAWA AYUMI (JP)
HASEGAWA TOORU (JP)
MATSUSHITA TAKASHI (JP)
TOKUNAGA YASUNORI (JP)
ONUMA KAZUHIRO (JP)
Application Number:
PCT/JP2022/042070
Publication Date:
May 19, 2023
Filing Date:
November 11, 2022
Export Citation:
Assignee:
UBE CORP (JP)
International Classes:
A61K31/506; A61K31/5377; A61P1/16; A61P11/00; A61P13/12; A61P43/00; C07D403/12; C07D403/14
Domestic Patent References:
| WO2021230325A1 | 2021-11-18 |
Foreign References:
| JP2006514050A | 2006-04-27 | |||
| JP2002511462A | 2002-04-16 | |||
| JP2019500355A | 2019-01-10 | |||
| JP2015524412A | 2015-08-24 | |||
| JP2002516287A | 2002-06-04 |
Attorney, Agent or Firm:
KOBAYASHI Hiroshi et al. (JP)
Download PDF: